메뉴 건너뛰기




Volumn 57, Issue 6, 1994, Pages 1477-1483

Isolated lung perfusion with tumor necrosis factor: A swine model in preparation of human trials

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR;

EID: 0028234354     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(94)90104-X     Document Type: Article
Times cited : (31)

References (23)
  • 2
    • 0023130601 scopus 로고
    • Studies on the antitumor efficacy of systemically administered recombinant tumeur necrosis factor against several murine tumors in vivo
    • (1987) J Immunol , vol.138 , pp. 963-974
    • Asher1    Mule2    Reichert3    Shiloni4    Rosenberg5
  • 4
    • 0026531756 scopus 로고
    • High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
    • (1992) J Clin Oncol , vol.10 , pp. 52-60
    • Lienard1    Ewalenko2    Delmotti3    Renard4    Lejeune5
  • 10
    • 0022396366 scopus 로고
    • Isolated total lung perfusion as a means to deliver organ-specific chemotherapy: long-term studies in animals
    • (1985) Surgery , vol.98 , pp. 35-44
    • Johnston1    Christensen2    Minchin3
  • 15
    • 0026065210 scopus 로고
    • Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvascular endothelial monolayers
    • (1991) Am J Pathol , vol.138 , pp. 93-101
    • Meyrick1    Christman2    Jesmok3
  • 18
    • 0024426529 scopus 로고
    • Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients
    • (1989) Ann Surg , vol.210 , pp. 474-485
    • Rosenberg1    Lotze2    Yang3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.